Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2673-2678

  Collins, Amy L ^a   Rock, Jonathan ^a   Malhotra, Lavina ^a   Frankel, Wendy L ^a   Bloomston, Mark ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; SURVIVAL PREDICTION; TISSUE MICROARRAY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OSTEOPONTIN; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864965633     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2337-z     Document Type: Article

References (20)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin. 60 277 300 20610543 10.3322/caac.20073
2. C Sharma KM Eltawil PD Renfrew MJ Walsh M Molinari 2011 Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010 World J Gastroenterol. 17 867 897 21412497 10.3748/wjg.v17.i7.867
3. D Li K Xie R Wolff JL Abbruzzese 2004 Pancreatic cancer Lancet. 363 1049 1057 15051286 10.1016/S0140-6736(04)15841-8 1:CAS:528:DC%2BD2cXisFOmsLY%3D
4. B Farrow DH Berger D Rowley 2009 Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2 J Surg Res. 156 155 160 19592030 10.1016/j.jss.2009.03.040 1:CAS:528: DC%2BD1MXhtVegtr7L
5. A Neesse P Michl KK Frese, et al. 2011 Stromal biology and therapy in pancreatic cancer Gut. 60 861 868 20966025 10.1136/gut.2010.226092
6. M Erkan C Reiser-Erkan CW Michalski J Kleeff 2010 Tumor microenvironment and progression of pancreatic cancer Exp Oncol. 32 128 131 21403605 1:STN:280:DC%2BC3M3ms1yitg%3D%3D
7. A Kolb J Kleef A Guweidi, et al. 2005 Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions Cancer Biol Ther. 4 740 746 15970685 10.4161/cbt.4.7.1821 1:CAS:528:DC%2BD28XjtlWktLY%3D
8. J Cheng DH Huo DM Kuang J Yang L Zheng SM Zhuang 2007 Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells Cancer Res. 67 5141 5147 17545592 10.1158/0008-5472.CAN-06-4763 1:CAS:528:DC%2BD2sXmtVaisLY%3D
9. Fedarko NS, Jain A, Karadag A, Fisher LW. SIBLING interactions with complement factor H and pro-matrixmetalloproteinases. Presented at the Third International Conference on Osteopontin and SIBLING Proteins, San Antonio, TX, 2002.
10. Y Wu DT Denhardt SR Rittling 2000 Osteopontin is required for full expression of the transformed phenotype by the ras oncogene Br J Cancer. 83 156 163 10901364 10.1054/bjoc.2000.1200 1:CAS:528:DC%2BD3cXltl2muro%3D
11. AJ Oates R Barraclough PS Rudland 1996 The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model Oncogene. 13 97 104 8700559 1:CAS:528:DyaK28Xks1ens7g%3D
12. V Ophascharoensuk CM Giachelli K Gordon, et al. 1999 Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis Kidney Int. 56 571 580 10432396 10.1046/j.1523-1755.1999.00580.x 1:CAS:528: DyaK1MXltlOgsr0%3D
13. HW Pan YH Ou SY Peng, et al. 2003 Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer. 98 119 127 12833464 10.1002/cncr.11487 1:CAS:528:DC%2BD3sXlslagur4%3D
14. S Schneider J Yochim J Brabender, et al. 2004 Osteopontin but not osteopontin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer Clin Cancer Res. 10 1588 1596 15014008 10.1158/1078-0432.CCR-0565-3 1:CAS:528:DC%2BD2cXhvFClsb4%3D
15. PS Rudland A Platt-Higgins M El-Tanani, et al. 2002 Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res. 62 3417 3427 12067984 1:CAS:528:DC%2BD38XkslWqsb0%3D
16. J Koopmann NS Fedarko A Jain, et al. 2004 Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev. 13 487 491 15006928 1:CAS:528:DC%2BD2cXhvVygtL4%3D
17. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
18. LB De Lott C Morrison S Suster DE Cohn WL Frankel 2005 CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites Arch Pathol Lab Med. 129 1100 1105 16119980
19. M Ahmed GC Kundu 2010 Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NK-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells Mol Cancer. 9 101 20459645 10.1186/1476-4598-9-101
20. CA Iacobuzio-Donahue A Maitra GL Shen-Ong, et al. 2002 Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol. 160 1239 1249 11943709 10.1016/S0002-9440(10)62551-5 1:CAS:528:DC%2BD38XjsFGjsbY%3D